The extent of residual WT HSPCs is associated with the degree of anemia in patients with <i>SF3B1</i>-mutated MDS-RS-Reference-Cited by-同舟云学术

The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS

Published:2022-08-12 Issue:16 Volume:6 Page:4705-4709
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Hofman Isabel Juliana F.¹,Mortera-Blanco Teresa¹,Moura Pedro Luis¹^ORCID,Vestlund Johanna¹^ORCID,Larsson Sigita Venckute¹,Elvarsdottir Edda M.¹,Walldin Gunilla¹,Tobiasson Magnus¹²^ORCID,Sander Birgitta³,Dimitriou Marios¹⁴,Jacobsen Sten-Eirik W.¹²⁴,Woll Petter S.¹⁴^ORCID,Jädersten Martin²,Hellström-Lindberg Eva¹²

Affiliation:

1. 1Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden;

2. 2Department of Hematology, Karolinska University Hospital, Huddinge, Sweden;

3. 3Department of Laboratory Medicine, Division of Pathology, Karolinska University Hospital, Huddinge, Sweden; and

4. 4Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/6/16/4705/1913237/advancesadv2022007858.pdf

Reference17 articles.